Creative Testing Solutions
Creative Testing Solutions is a 501(c)(3) nonprofit laboratory that performs infectious disease and specialty testing on blood, plasma, tissue, organ, and cellular therapy donations for over 100 healthcare partners across seven U.S. facilities, owned by American Red Cross, OneBlood, and Vitalant.
- Company typePrivate
- Founded2018
- HeadquartersTempe, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What Creative Testing Solutions does
Creative Testing Solutions (CTS) is a U.S.-based 501(c)(3) nonprofit laboratory services organization that performs infectious disease and specialty testing on blood, plasma, tissue, organ, and cellular therapy donations on behalf of healthcare partners. CTS was formed in January 2018 through a merger with three American Red Cross testing laboratories (Charlotte, Portland, St. Louis) and expanded to seven laboratories in April 2022 by assuming operations of three Grifols facilities in San Marcos TX, Austin TX, and Memphis TN. The company is jointly owned by American Red Cross, OneBlood, and Vitalant and is governed by a 13-member board drawn from these owner organizations. CTS tests ~9 million donor samples annually (4.9 million source plasma and 4.5 million blood donor samples as of 2016), with reported on-time result delivery of approximately 92%, and partners with over 100 healthcare entities across the U.S.
CTS's core service lines are Donor Testing (high-volume blood screening at five labs), Plasma Testing (full-spectrum source and recovered plasma testing including 5 NAT, viral markers, and ancillary assays), and a Phoenix-based Special Testing Laboratory performing confirmatory and supplemental testing, donor re-entry, and screening for eye/tissue/organ donors, cord blood, and cellular therapy collections. Testing is performed on FDA-licensed platforms from Grifols (Procleix Ultrio Elite on Panther), Ortho Clinical Diagnostics (VIP viral marker, VISION analyzer, Vitros Anti-SARS-CoV-2), Bio-Rad (Geenius HIV 1/2 Supplemental), and Stratec Biomedical (Gemini for HLA), with all facilities holding FDA registration, CLIA accreditation, AABB accreditation, and EU/AGES certification. Supporting infrastructure includes the CTS Connect client portal and the PACE Training e-learning platform, plus a Phoenix-based R&D department that supports clinical trials and research studies for federal, state, international, academic, and NGO sponsors.
CTS operates a managed services / professional services revenue model: B2B laboratory testing is delivered through direct enterprise relationships negotiated via a dedicated Client Services team, with samples shipped from healthcare partners to CTS labs and results delivered through CTS Connect. The go-to-market is enterprise field sales targeting blood banks, blood centers, plasma collection centers, plasma fractionators, and specialty donor programs. CTS has roughly 1,000 team members across its seven U.S. facilities, with no public equity, venture, or private equity investment; capital formation and governance are tied to the three owner organizations. Recent strategic priorities have been platform modernization (Ortho VIP in 2021, Grifols Panther conversions in 2019–2020), rapid deployment of emerging-pathogen assays (COVID-19 and Babesia in 2020), and international scientific engagement (IPFA Executive Board membership via VP of Scientific Affairs Marion Lanteri).
Creative Testing Solutions firmographics
Firmographics- Name
- Creative Testing Solutions
- Legal name
- Creative Testing Solutions
- Website
- https://mycts.org
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Creative Testing Solutions is a 501(c)(3) nonprofit laboratory that performs infectious disease and specialty testing on blood, plasma, tissue, organ, and cellular therapy donations for over 100 healthcare partners across seven U.S. facilities, owned by American Red Cross, OneBlood, and Vitalant.
- Ownership category
- akta.pro rank
Where Creative Testing Solutions is headquartered
LocationHeadquarters
- HQ city
- Tempe
- HQ country
- United States
- HQ region
- North America
Offices7 records
Markets served
Creative Testing Solutions business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure
Revenue model
- Blood Donor Testing Services: Laboratory testing services for blood donation samples testing all infectious disease markers and screening tests required by FDA and other regulatory bodies
- Plasma Testing Services: Testing services for source plasma and recovered plasma including 5 NAT, viral marker and all required ancillary testing
- Special Testing Services: Specialized confirmatory and supplemental testing, eye/tissue/organ donor testing, and cellular therapy testing services
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
Creative Testing Solutions product offering
Product offeringCore offering
Creative Testing Solutions (CTS) is a nonprofit 501(c)(3) blood and plasma donor testing laboratory that performs specialized infectious disease and immunohematology testing on donated blood and source plasma. Operating 7 facilities across the U.S. and partnering with more than 100 healthcare entities, CTS provides high-throughput donor screening, confirmatory testing, and specialized laboratory services for blood banks, plasma collection centers, and other biologics manufacturers.
Product overview
Creative Testing Solutions is a nonprofit blood and plasma donor testing laboratory organization operating as a single integrated service. The core offerings include Donor Testing (blood screening at five high-volume labs), Plasma Testing (full spectrum plasma testing including NAT and viral markers), and a Special Testing Laboratory (confirmatory/supplemental testing in Phoenix). Supporting infrastructure includes CTS Connect (client portal), PACE Training (e-learning platform), and Research & Development services. The company operates seven facilities across the US and partners with over 100 healthcare entities. Testing is performed using FDA-licensed platforms including Grifols Procleix systems, Ortho systems, and Stratec Gemini, with all labs holding FDA registration, CLIA accreditation, AABB accreditation, and EU certifications.
Differentiator
Problem solved
Functional benefit
Products and services
- Donor Testing
- Plasma Testing
- Special Testing Laboratory
- Research & Development
- CTS Connect
Quantifiable outcome
- Approximately 92% on-time test result reporting
- +1 more outcomes
Companies that use Creative Testing Solutions
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles1 record
Creative Testing Solutions technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
Creative Testing Solutions partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- GrifolscoreOn April 1, 2022, CTS assumed responsibility for operations of Grifols' three testing facilities in San Marcos TX, Austin TX, and Memphis TN. Partnership involves Grifols ZIKV assay licensed testing, Procleix Ultrio Elite assay on Panther platform, and Babesia testing using Grifols licensed tests.
Scale indicators6 records
Recent moves7 records
Expansion highlights5 records
Creative Testing Solutions competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Creative Testing Solutions social profiles
Digital presenceCreative Testing Solutions compliance and trust
Trust signalCompliance6 records
Creative Testing Solutions financial estimates
Financial estimateRevenue estimate
Valuation estimate
Creative Testing Solutions leadership team
Management profileNumber of profiles
Creative Testing Solutions funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Creative Testing Solutions M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Creative Testing Solutions
What does Creative Testing Solutions do?
Creative Testing Solutions (CTS) is a nonprofit 501(c)(3) blood and plasma donor testing laboratory that performs specialized infectious disease and immunohematology testing on donated blood and source plasma. Operating 7 facilities across the U.S. and partnering with more than 100 healthcare entities, CTS provides high-throughput donor screening, confirmatory testing, and specialized laboratory services for blood banks, plasma collection centers, and other biologics manufacturers.
Is Creative Testing Solutions a public or private company?
Creative Testing Solutions is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Creative Testing Solutions founded?
Creative Testing Solutions was founded in 2018. It employs 501 to 1,000 people.
Where is Creative Testing Solutions based?
Creative Testing Solutions is headquartered in Tempe, United States, in the North America region.
How does Creative Testing Solutions make money?
Three revenue lines are on record. Blood Donor Testing Services are the primary driver. The others are plasma Testing Services and special Testing Services.
Does Creative Testing Solutions have an API?
No public API is recorded for Creative Testing Solutions.